BROCHURE: Beacon Quest™ Optofluidic System for Academic Research

The Beacon Quest™ is an automated 2-chip optofluidic system that allows you to run thousands of miniaturized single-cell assays in parallel and then recover cells of interest.

INFO SHEET: Detection Reagents for the Custom Productivity Assay

Detection reagents for the Custom Productivity and Bispecific Heterodimer Assays are fluorescent molecules that bind to the secreted protein of interest and are used to quantify the amount of this protein produced by the cells being assayed.

APP NOTE: Identify Top Producing Clones with Favorable Product Quality Attributes | A4

• Identify clones with favorable growth, titer, and product quality attributes prior to scale up
• Go from transfected pools to top clones in under one week for a wide variety of protein therapeutics, including protein-based vaccines,
  enzymes and bispecific molecules
• Cloning efficiencies 5x greater than FACS and 10x greater than limiting dilution, and >99% monoclonality assurance

APP NOTE: Identify Top Producing Clones with Favorable Product Quality Attributes

• Identify clones with favorable growth, titer, and product quality attributes prior to scale up
• Go from transfected pools to top clones in under one week for a wide variety of protein therapeutics, including protein-based vaccines,
  enzymes and bispecific molecules
• Cloning efficiencies 5x greater than FACS and 10x greater than limiting dilution, and >99% monoclonality assurance

BROCHURE: Beacon Select™ Optofluidic System for CLD | A4

• Approximately half the price of the 4-chip Beacon system
• A 2-chip automated optofluidic system, similar to the 4-chip Beacon® optofluidic system, which provides well-established workflows that have been adopted by ~130 customers
• Throughput scaled to meet the needs of small to mid-sized biopharma and CDMO/CRO companies

BROCHURE: Beacon Select™ Optofluidic System for CLD

• Approximately half the price of the 4-chip Beacon system
• A 2-chip automated optofluidic system, similar to the 4-chip Beacon® optofluidic system, which provides well-established workflows that have been adopted by ~130 customers
• Throughput scaled to meet the needs of small to mid-sized biopharma and CDMO/CRO companies

DATASHEET: Opto® Cell Line Development Workflow | A4

• Selective Cell Cloning for better clones and accelerated campaign timelines
• Custom Productivity Assay for selection of cell lines expressing a wide range of therapeutic proteins and vaccines

DATASHEET: Opto® Cell Line Development Workflow

• Selective Cell Cloning for better clones and accelerated campaign timelines
• Custom Productivity Assay for selection of cell lines expressing a wide range of therapeutic proteins and vaccines

INFO SHEET: TechAccess Subscriptions

TechAccess Subscriptions provide access to Berkeley Lights’ revolutionary workflows no matter
the size of your lab, your customer base, or budget.

eBook: How to Get More Molecules to the Clinic Faster with Automated Cell Line Development

Learn how our Opto CLD workflow can help remove the bottleneck from traditional cell line development.

Webinar: Bring Product Quality Assessment into Early Clone Selection with Opto™ Cell Line Development

CHO cell line selection represents a painful bottleneck in biotherapeutic development, particularly for complex molecules like bispecifics. At BPI Europe Digital Week 2021, Renee Tobias discussed how the Opto™ CLD workflow on the Beacon® system can help through accelerating early CLD by integrating high throughput cell sorting, cloning, culture, productivity, growth, and product quality assays into a single, 5-day automated process.

Customer Spotlight: Amgen on the Berkeley Lights Platform

Philip Tagari, VP Therapeutic Discovery, Amgen, discusses how the Berkeley Lights’ platform has transformed the way Amgen approaches antibody discovery and cell line development.

App Note: Bring Product Quality Assessment into Early Clone Selection with the Opto™ Assure Aggregation Assay

Read this application note to learn more about how to get early, multi-parameter assessment of clones with the Opto Assure assay series.

Brochure: Get to Market Faster with the Opto CLD Workflow

Find out how the Opto CLD workflow sets a new standard for quality, capacity, and speed in cell line development to let BioPharma get more molecules to the clinic faster. 

Brochure: Increase CDMO Revenue with the Opto CLD Workflow

Find our how the Opto CLD workflow sets a new standard for quality, capacity, and speed in cell line development and allows CDMOs to scale operations and drive new business. 

Webinar: Leveraging Innovative Technologies to Accelerate Biologics Development

At the 2021 BPS EU virtual conference, Beacon user Joaquina Mascarenhas, PhD, at Thermo Fisher Scientific shares how the Berkeley Lights Platform enables their cell line development to move at world class speed and select the best clones.

Webinar: Accelerating Discovery and Development of Antibody Therapeutics

Hear from BLI experts Renee Tobias and Anupam Singhal about the unique benefits to leveraging a single platform for both the identification of promising candidates and the production of leading therapeutic molecules.

App Note: FDA-Accepted Monoclonality Assurance on the Beacon® Optofluidic System for Cell Line Development

Learn how the Beacon system’s superior cloning technology, automated imaging capabilities, and in-process quality controls provide definitive evidence of monoclonality to support regulatory approvals.